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Abstract 
Hydrogen sulfide (H2S) is an endogenously produced gas that is toxic at high 
concentrations. It is disposed of by a dedicated mitochondrial sulfide oxidation pathway, 
which connects to the electron transfer chain at the level of complex III. Direct reduction of 
cytochrome C (Cyt C) by H2S has been reported previously but not characterized. In this 
study, we demonstrate that reduction of ferric Cyt C by H2S exhibits hysteretic behavior, 
which suggests the involvement of reactive sulfur species in the reduction process and is 
consistent with a reaction stoichiometry of 1.5:1.0 mole Cyt C reduced:H2S oxidized. H2S 
increases O2 consumption by human cells (HT29 and HepG2) treated with the complex III 
inhibitor antimycin A, which is consistent with the entry of sulfide-derived electrons at the 
level of complex IV. Cyt C-dependent H2S oxidation stimulated protein persulfidation in vitro 
while silencing of Cyt C expression decreased mitochondrial protein persulfidation in cell 
culture. Cyt C released during apoptosis was correlated with persulfidation of procaspase 9 
and with loss of its activity. These results reveal a potential role for the electron transfer 
chain in general, and Cyt C in particular, for potentiating sulfide-based signaling.  
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H2S is an energy source for prokaryotes adapted for life in sulfide rich environments, but it is 
a potent respiratory toxin for other organisms. The targets of H2S poisoning are the metal 
centers in cytochrome c oxidase, the terminal station in the mitochondrial electron transfer 
chain (ETC).1,2 At low concentrations however, H2S modulates physiological processes 
ranging from inflammation to cardiovascular function and apoptosis.3–5 Cellular H2S levels 
must therefore be maintained within a nontoxic window by regulating enzymes involved in its 
biogenesis6–9 and degradation.10,11 The mitochondrial sulfide oxidation pathway transfers 
electrons from H2S oxidation to complex III via coenzyme Q.12 In red blood cells lacking 
mitochondria, a non-canonical sulfide oxidation route uses ferric hemoglobin and catalyzes 
conversion of H2S to thiosulfate.13 Polysulfides that are also produced in this reaction, are 
degraded by reductants such as glutathione.14 Other hemeproteins like myoglobin15 and 
neuroglobin16 also catalyze ferric heme-dependent H2S oxidation. Unlike hemoglobin and 
myoglobin, H2S oxidation by neuroglobin, in which the heme has two axial histidine ligands, 
does not involve direct coordination of sulfide to ferric iron.  
Cytochrome c (Cyt C) resides in the mitochondrial intermembrane space and shuttles 
electrons between complexes III and IV in the ETC. Release of Cyt C into the cytosol 
triggers apoptotic activation of caspase 9.17 As in neuroglobin, the heme in Cyt C is 6-
coordinate and exhibits bis-His or His/Met ligation. In principle, electrons from the oxidation 
of H2S can enter the ETC at the level of complex IV either directly,18 or indirectly via initial 
reduction of ferric Cyt C by sulfide.19 However, the standard redox potential  for the S•–, 
H+/HS– couple is +0.91 V (vs. NHE)20 compared to +0.26 V for Cyt C,21 rendering reduction 
of Cyt C by H2S thermodynamically unfavorable. Yet, reduction of Cyt C by sulfide has been 
observed in vitro,19,22 and in the ciliated gills of Guenkensia demissa, a mussel that lives in 
sulfide-rich sediments.23 An additional link between H2S and Cyt C was reported in a study 
on rotenone-induced apoptosis in which H2S exposure preserved mitochondrial function, 
limited Cyt C release, and inhibited dissipation of the mitochondrial proton membrane 
potential.24 However, a quantitative analysis of H2S oxidation by Cyt C, identification of the 
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reaction products, and elucidation of its effects on apoptosis and persulfide signaling has 
been lacking.  
In this study, we report the kinetics of Cyt C reduction by H2S, demonstrate formation of 
thiosulfate as a reaction product, and show stimulation of O2 consumption in human cells 
treated with antimycin A, consistent with the delivery of electrons from H2S to complex IV via 
Cyt C. We also demonstrate that Cyt C in the presence of H2S stimulates protein 
persulfidation suggesting a potentiating role of the ETC in H2S-dependent signaling in 
general and in regulation of apoptosis via persulfidation of caspase 9 in particular. 
 
Results and Discussion 
Kinetics of Cyt C reduction by sulfide. Addition of stoichiometric H2S to ferric Cyt C 
(Soret at 409 nm) results in its complete conversion to the ferrous form (415 nm) with 
sharpening of the α/β bands at 550 and 520 nm (Fig. 1A). The kinetics of Cyt C reduction by 
sulfide exhibits a pronounced lag phase (Fig. 1B) indicating that either the reaction involves 
a slow step (e.g. ligand exchange from histidine to HS–) or that it is accelerated as H2S 
oxidation products accumulate. Cryo-ESI MS previously used to observe HS– coordination to 
ferric heme,15 did not identify a comparable adduct with Cyt C (Supporting Fig. 1). The 
stoichiometry of the reduction reaction (1.5:1.0 Cyt C:sulfide) was independent of the 
presence of O2 (Fig. 1 C). The Cyt C reduction rate showed a bell-shaped dependence on 
pH with a maximum at 7.5 and inflection points at 6.7 ± 0.1 and 8.5 ± 0.1 (Fig. 1D). 
Phosphate and citrate buffers, previously shown to bind Cyt C and influence its overall 
charge and redox potential,25 significantly inhibited the rate of ferric Cyt C reduction by 
sulfide (not shown).  
As discussed above, the one electron reduction of Cyt C with HS– is thermodynamically 
unfavorable, which could explain the observed lag phase (Fig. 1B). In principle, HS•/S•– could 
dimerize at a diffusion-controlled rate (k = 9 × 109 M–1 s–1)2 giving HS2– (eq 1). However, the 
probability of HS•/S•– reaching sufficiently high concentrations for the dimerization reaction 
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Figure 1. Reduction of Cyt C by sulfide. (A) The initial spectrum of ferric Cyt C (10 µM) in 
100 mM HEPES buffer, pH 7.4 (red) shifts in the presence of 10 µM Na2S (at 3, 5, 7, 10, 15, 
and 20 min, black lines) under aerobic conditions at 25 oC. (B) Kinetics of aerobic Cyt C 
reduction (10 µM) at 3, 5 and 10 µM Na2S in 100 mM HEPES buffer, pH 7.4 at 25 oC. (C) 
Percent Cyt C (10 µM in 100 mM HEPES buffer, pH 7.4) reduction as a function of sulfide 
concentration. The increase in absorbance at 550 nm was monitored after 1 h incubation 
with sulfide at 25 oC under aerobic or anaerobic conditions. The red line is a sigmoidal fit to 
the experimental data with S0.5 = 2.9 ± 0.1 µM and n = 2.4 ± 0.2. (D) The pH dependence of 
Cyt C reduction by sulfide. The rate of Cyt C (2.5 µM) reduction by sulfide (500 µM) was 
determined by anaerobic stopped-flow spectroscopy as described under Methods. The data 
are the mean ± SD of 4 independent experiments as described under Methods. From the fit, 
estimates for pKa1 and pKa2 of 6.7 ± 0.1 and 8.5 ± 0.1, respectively were obtained. 
 
is likely to be low. Furthermore, formation of HS2– would not provide the driving force for Cyt 
C reduction, as the reaction (eq. 2) is thermoneutral (E°ʹ (Cyt C3+/Cyt C2+) = +0.26 V, E°ʹ 
(S2•–, H+/HS2–) = +0.27 V).2,20  
S•–+ HS• → HS2–     (eq 1) 
Cyt C3+ + HS2– → Cyt C2+ + HS2•   (eq 2) 
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Alternatively, O2 could react with the initially formed HS•/S•– at a diffusion-controlled rate (k = 
5 × 109 M–1 s–1)2 to produce SO2•–, a strong reducing agent (eqs. 3-4). However, the extent of 
Cyt C reduction was independent of O2 (Fig. 1C). 
S•– + O2 → SO2•–     (eq 3) 
Cyt C3+ + SO2•–→ Cyt C2+ + SO2    (eq 4) 
An alternative mechanism to explain the hysteretic behavior is that the initially formed 
HS•/S•– reacts with HS– (kon = 4 × 109 M–1 s–1, koff = 5 × 103 M–1 s–1)2,20 forming H2S2•–, which is 
a strong reducing agent (E°ʹ (HS2–, H+/H2S2•–) = -1.13 V)2,20 and could pull the Cyt C 
reduction reaction forward. Interestingly, Na2S2 reduced Cyt C more rapidly than sulfide and 
without an observable lag phase (Fig. 2A). 
Degradation of excess sulfide in the presence of Cyt C. Biphasic O2 consumption 
kinetics were seen when Cyt C was mixed with excess sulfide (Fig. 2B). As the ratio of 
sulfide to Cyt C concentration was increased, the amplitude of the initial burst phase and the 
slope of the slow phase increased. This data is consistent with the model that the burst 
phase corresponds to the reduction of Cyt C during which the initially formed HS•/S•– is 
rapidly oxidized, while the slow phase represents subsequent oxidation reactions. The 
amplitude of the burst phase showed a hyperbolic dependence on sulfide concentration and 
asymptotically approached 0.7 equivalents of Cyt C to O2 consumed (Fig. 2C). Biphasic O2 
consumption suggested formation of products with higher sulfur oxidation states. SO2 
formation (eq 4) would result in accumulation of sulfite, which in the presence of a sulfane 
sulfur donor (“S”) would form thiosulfate as a final product (eq 5-6).2  
SO2 + H2O → HSO3– + H+     (eq 5) 
HSO3– + “S” → S2O32– + H+     (eq 6) 
We tested for the formation of sulfide oxidation products under aerobic conditions (Fig 2D). 
Loss of sulfide was paralleled by the accumulation of thiosulfate and to a lesser degree, 
sulfite. The recovery of sulfur equivalents in the thiosulfate, which has two sulfur atoms  
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Figure 2. Cyt C reduction kinetics and product analysis. (A) Kinetics of aerobic Cyt C 
reduction (10 µM) in the presence of 3, 5 and 10 µM Na2S2 in 100 mM HEPES buffer, pH 7.4 
at 25 oC. Complete reduction with equimolar Na2S2 was seen within 5-10 min. (B) Kinetics of 
O2 consumption in the presence of Cyt C and sulfide. Addition of sulfide to Cyt C (50 µM in 
100 mM HEPES buffer, pH 7.4) at 25 oC results in rapid initial consumption of O2 followed by 
a slower phase. (C) Dependence of the concentration of O2 consumed in the burst phase on 
sulfide concentration. A hyperbolic fit to the data (mean±SD of 3-5 independent 
experiments) gives a Kact of 0.5 ± 0.1 mM and a maximal O2 consumed of 35±2 µM (red line) 
yielding a stoichiometry of 0.7:1.0 for O2 consumed:Cyt C. (D) Consumption of sulfide and 
accumulation of thiosulfate and sulfite 2 h after addition of 800 µM Na2S to 100 mM HEPES 
buffer, pH 7.4 without (black bars) or with (gray bars) 100 µM Cyt C at 25 oC under aerobic 
conditions. The initial levels of sulfide, thiosulfate, and sulfite were 756, 25, and 3.5 µM 
respectively. (E) MS detection of sulfur products formed in the reaction of 10 µM Cyt C with 
100 µM H2S in ammonium carbonate buffer, pH 7.7, under aerobic conditions. The reaction 
was monitored for 15 min at room temperature. The observed spectrum is at the top and the 
simulated spectra with isotopic distribution are below.  
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(∼280 µM), and sulfite (40 µM) pools represent ~50% of the sulfide lost. Due to interference 
of Cyt C with the cold cyanolysis method, we were unable to evaluate the concentration of 
sulfane sulfur species in the reaction mixture. ESI-TOF MS in the negative mode confirmed 
formation of thiosulfate and also revealed the presence of sulfate (Fig. 2E). Although sulfite 
was not seen (possibly due to its low m/z), we detected the sulfur trioxide radical anion SO3•–
, which increased in concentration with time (Supporting Fig. 2). Both SO2•– and H2S2•– 
readily reduce O2 to form superoxide that can disproportionate to give H2O2.2,20 The latter 
can oxidize ferrous Cyt C, enabling its redox cycling.26,27 Sulfite, peroxide and heme proteins 
are known to produce SO3•– which is a potent oxidant that is proposed to play a role under 
certain pathological conditions.28–30 SO3•– could also contribute to Cyt C re-oxidation to 
establish a pseudo-catalytic cycle for H2S removal. 
 
Cyt C stimulates in vitro protein persulfidation. Protein thiols represent a potentially large 
pool of intracellular HS•/S•– scavengers (eq 7). To test the hypothesis that protein thiols are 
S•– + RSH → RSSH•–    (eq 7) 
sinks for HS•/S•–, we first used time-resolved ESI-TOF-MS to monitor a reaction mixture 
containing Cyt C, H2S and cysteine. Formation of cysteine persulfide (as [CysSSH +H]+ and 
[2CysSSH + H]+ ions) and its decay products CysSSCys (Fig. 3A) and CysSSSCys 
(Supporting Fig. 3A) was observed. While formation of CySSH plateaued within 1 min, 
formation of CysSSCys continued (Fig. 3B, Supporting Fig. 3B) supporting our previous 
report of the lability of CysSSH.31  
Next, we tested Cyt C-dependent persulfidation of a model protein, human serum 
albumin (HSA). We have previously shown that addition of water-soluble heme iron and H2S 
triggers protein persulfidation.32 Incubation of HSA with sulfide in the presence of Cyt C also 
resulted in protein persulfidation (detected using the Cy3-CN-based tag switch method)33 
that was proportional to the concentration of Cyt C (Fig. 3C). In contrast, when Cyt C was 
replaced with myoglobin, which oxidizes sulfide to polysulfides and thiosulfate via an inner  
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Figure 3. Cyt C stimulates H2S-dependent persulfidation. A) Mass spectrum of the 
reaction mixture (t = 6 min) containing 20 µM Cyt C, 100 µM H2S and 200 µM cysteine in 
ammonium carbonate buffer pH 7.7, 21 oC, and simulated isotopic distributions for some of 
the identified species: 1- [CysSH + H]+, 2- [CysSSH + H]+, 3- [CysSSCys + H]+, 4- 
[CysSSCys + Na]+, 5- [2CysSSH + H]+. B) Kinetics of [CysSSH + H]+ (m/z = 151.9) and 
[CysSSCys + H]+ (m/z = 241.0) formation. Data represent mean ± SD of 3 independent 
experiments. C) Persulfidation of HSA (10 µM) in PBS pH 7.4, incubated for 30 min at room 
temperature with 500 µM Na2S (lane 1) and 2 µM (lane 2), 20 µM (lane 3) and 200 µM (lane 
3) Cyt C. Data represent the mean ± SD; n=3, *p<0.001. D) Persulfidation of purified (1 µM) 
EHTE-1 and (10 µM) ATR treated with either 100 µM H2S (lane 1), 10 µM Cyt C (lane 2) or 
combination of both (lane 3). The results of two separate experiments are shown in the 
figure. Persulfidation (C-D) was detected by the CN-Cy3-based tag switch method (upper 
panels) while equal loading was detected by Coomassie blue staining (lower panels). The 
gel was artificially colorized using ImageJ to enhanced visualization of changes and the 
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fluorescence intensity scale is provided on the right. The persulfidation procedure is 
described in Supporting Materials and Methods. E) Aerobic kinetics of Cyt C (20 µM in 100 
mM HEPES buffer, pH 7.4 at 25 oC) reduction (monitored at 550 nm) by Na2S (20 µM) ± 
untreated or alkylated HSA (20 µM). Sulfide was added at time 0. F) Kinetics of O2 
consumption after addition of 0.2 mM Na2S to ferric Cyt C (50 µM in 100 mM HEPES buffer, 
pH 7.4) ± 50 µM HSA at 25 oC. 
 
sphere electron transfer mechanism, an increase in persulfidation was not observed 
(Supporting Fig. 4). The residual persulfidation signals seen in the control lanes result from 
H2S-induced reduction of the disulfide bond in HSA. We also demonstrated that the human 
mitochondrial proteins, ETHE-1 and adenosyltransferase (ATR), previously identified as 
persulfidation targets, were also persulfidated by Cyt C/H2S (Fig. 3D). 
Interception of reactive sulfur species (HS•/S•–) by cysteine residues on proteins should 
decrease the rate of Cyt C reduction by H2S and O2 consumption. A substantial decrease in 
the rate of Cyt C reduction was in fact observed in the presence of equimolar HSA, which 
was attenuated by prior alkylation of HSA cysteines with iodoacetamide (Fig. 3E). HSA also 
decreased the rate of O2 consumption impacting both the burst and slow phases of the 
reaction (Fig. 3F). Interestingly, the amplitude of the burst phase was increased in the 
presence of HSA. The initially formed RSSH•– protein radical anion is expected to be a 
strong reducing agent in analogy with RSSR•– (E°ʹ (RSSR/RSSR•–) = -1.4 V).34 Since outer 
sphere electron transfer from the protein radical to Cyt c is likely to be precluded by steric 
hindrance, O2 would be the only available electron acceptor (eq 8), which could explain the 
higher amplitude observed for the burst phase (Fig. 3F). 
RSSH•– + O2 → RSSH + O2•–    (Eq 8) 
 
Cyt C silencing decreases intracellular persulfidation. To further investigate its role in 
protein persulfidation, Cyt C was silenced in HeLa cells. Under normoxic conditions, Cyt C 
silencing resulted in a small but statistically significant decrease in endogenous protein 
persulfidation as detected by the CN-Cy3-based tag switch method (Fig. 4A). The 
mitochondria-targeted H2S donor AP39 caused a large increase in protein persulfidation as 
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seen previously,33 which was reduced by Cyt C siRNA treatment. The perinuclear 
localization of the persulfidation signal in AP39-treated cells confirms mitochondrial 
localization as reported for this donor.33,35,36  
 
Figure 4. Cyt C silencing decreases protein persulfidation. (A) Under normoxic 
conditions, silencing of Cyt C in HeLa cells (confirmed by Western-blot analysis) led to a 
small but measureable decrease in basal persulfidation levels, which was increased by the 
mitochondria-targeted H2S donor, AP39 (200 nM). Scale bar 5 µm. (B) Exposure of HeLa 
cells to hypoxia for 1 h results in increased endogenous H2S levels as detected by MeRho-
Az. Scale bar 10 µm. C) Under hypoxic conditions, the levels of protein persulfidation are 
high but significantly reduced by Cyt C silencing. Scale bar 10 µm. Representative 
microscopy images are given on the left and quantitative image analysis on the right. The 
results represent average fluorescence intensity (F. I.) detected from n≥ 40 cells ± SEM of 5 
independent images. *p < 0.001.  
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H2S oxidation is dependent on the presence of a functional ETC and lower O2 levels lead 
to H2S accumulation.37 Using MeRho-Az, a bright fluorescence probe for H2S detection,35 we 
observed a substantial increase in intracellular H2S in HeLa cells exposed to <5% O2 (Fig. 
4B). A significant increase in protein persulfidation was observed in cells exposed to hypoxic 
conditions, which was diminished by silencing Cyt C (Fig. 4C). 
 
Sulfide stimulates O2 consumption in complex III-inhibited cells. To assess whether 
electrons from sulfide oxidation can bypass complex III and enter at the level of complex IV 
(Fig. 5A), the O2 consumption rate (OCR) was assessed with human cells in suspension. 
The OCR decreased to 2.5% (HepG2) and 5% (HT29) of the initial values in the presence of 
antimycin A, a complex III inhibitor (Fig. 5B,C). Addition of sulfide (20 µM) increased OCR by 
an average of 30% (HT29) and 95% (HepG2) above the antimycin-treated value. Higher 
concentrations of sulfide (100 µM) inhibited O2 consumption as expected, presumably due to 
inhibition of complex IV. Addition of KCN, which poisons complex IV, blocked OCR 
confirming that O2 consumption induced by sulfide was linked to mitochondrial respiration. 
Next, we assessed how inhibition of complex III and IV affects persulfidation in functional 
mitochondria that should produce H2S via the action of 3-mercaptopyruvate 
sulfurtransferase. Purified yeast mitochondria (Saccharomyces cerevisiae) treated with 
antimycin A showed an increase in intra-mitochondrial protein persulfidation, an effect that 
was inhibited by KCN (Fig. 5D). This is in accordance with our hypothesis that even when 
H2S oxidation is inhibited by antimycin A, Cyt C-dependent consumption of H2S can still 
occur, leading to increased protein persulfidation. Inhibition of cytochrome C oxidase (by 
KCN) on the other hand, would prevent reoxidation of Cyt C and stop the cycle (Fig. 5D). 
Collectively, these results suggest that the canonical sulfide oxidation pathway can be 
ypassed to some extent by direct reduction of Cyt C. The reactive sulfur species formed  
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Figure 5. Sulfide stimulates O2 consumption by mammalian cells and controls persulfidation 
of mitochondrial proteins. (A) Cartoon showing electrons from H2S oxidation enter the ETC 
at the level of complex III via the reduced quinone pool. Entry into complex IV via Cyt C can 
be monitored in the presence of antimycin A, a complex III inhibitor. (B and C) O2 
consumption rates of HT29 (B) and HepG2 (C) cells before (control) and after treatment with 
2 µg ml–1 antimycin A (AA) followed by 20 µM Na2S. Finally, antimycin A-treated cells were 
exposed to 5 mM KCN. The data are the mean±SD of 12 (B) or 6 (C) independent 
experiments; p value shows the statistical significance for the difference between antimycin 
A ± sulfide treated cells. D) Protein persulfidation in purified mitochondria is affected by ETC. 
Functional mitochondria were isolated from S. cerevisiae and preincubated with 2.5 µg ml–1 
antimycin A or 10 mM KCN for 10 min at 37 ˚C or treated with 1 µM H2S for 20 min at 37 ˚C. 
Persulfidation was monitored by improved tag-swtich method. First lane represents the basal 
persulfidation level in untreated functional mitochondria. Total protein load is shown in the 
gel on the right. 
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under these conditions can react with protein thiols increasing persulfidation. We speculate 
that this situation could be particularly important in ischemia/reperfusion, protecting proteins 
from ROS-induced hyper-oxidation during the reperfusion phase. 
 
Cyt C-induced persulfidation controls caspase 9 activity. In addition to its role in 
mitochondrial energy metabolism, Cyt C is an important regulator of apoptosis following its 
release into the cytosol.38,39 In the presence of Cyt C, apoptotic protease activating factors in 
the apoptosome activate procaspase 9, triggering a protease cascade.40 Due to this 
functional association with Cyt C, we tested whether caspase 9, a cysteine protease, is 
persulfidated in the presence of H2S and Cyt C. Incubation with Cyt C and H2S stimulated 
persulfidation of recombinant murine procaspase 9 (Fig. 6A). Next, we assessed caspase 9 
activity in HeLa cell extracts using the fluorogenic caspase-9 substrate. Cyt C significantly 
stimulated caspase 9 activity, which was diminished in the presence of sulfide (Fig. 6B). 
Activity of caspase 9 in intact cells was also assessed by flow cytometry in Jurkat cells 
treated with staurosporine, an apoptosis inducer.41 Staurosporine induced caspase 9 activity 
(Fig. 6C), which was prevented by the slow-releasing H2S donor, 100 µM GYY4137. In 
contrast, the faster-releasing H2S donor, ammonium tetrathiomolybdate, only partially 
inhibited the effect of staurosporine on caspase activation (Fig. 6C).  
Procaspase 3 is the downstream target of caspase 9, which cleaves it to the active 
caspase 3 form.42 Induction of apoptosis by antimycin A treatment of HeLa cells for 16 h 
resulted in the expected increase in caspase 3 activity, which was partially inhibited by pre-
incubating the cells for 2h with GYY4137 (Fig. 6D). 
Finally, we checked whether persulfidation of procaspase 9 was affected in HeLa cells 
treated with staurosporine for 6 h. Cells were either pre-treated with GYY4137 prior to 
staurosporine addition or treated for 2h after induction of apoptosis by staurosporine 
(Supporting Fig. 5A). GYY4137 treatment decreased total procaspase 9 levels (Fig. 6E). 
Persulfidation of procaspase 9 was however significantly increased when the cells were 
treated with both staurosporine and the H2S donor (Fig. 6E, Supporting Fig. 5B).  
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Figure 6. Cyt C-mediates procaspase 9 persulfdation and activity. (A) Murine 
recombinant procaspase 9 (1 µM) was incubated with 5 µM H2S for 30 min at 37 ˚C in the 
absence (lane 1) or presence of 0.5 (lane 2) and 2 µM (lane 3) Cyt C. Persulfidation was 
detected by the CN-Cy3-based tag switch method (upper panel) while equal loading was 
confirmed by Coomassie blue staining (lower panel).  B) H2S inhibits Cyt C-induced caspase 
9 activation in cell lysates. Cyt C (500 nM) was added to freshly prepared HeLa cell lysates 
and caspase 9 activity was monitored using a fluorescence caspase 9 kit. Simultaneous 
addition of Cyt C and H2S (10 µM) inhibited the Cyt C-induced increase in fluorescence. C) 
Cyt C-induced caspase 9 activation in Jurkat cells is inhibited by H2S donors. Apoptosis was 
induced by staurosporine (ST, 2.5 µM) and caspase 9 activity was monitored by flow 
cytometry using the caspase 9 FITC Staining Kit 4 and 6 h after induction. Treatment of cells 
with (GYY4137, 100 µM) or ammonium tetrathiomolybdate (ATTM, 200 µM) reduced 
fluorescence. D) Inhibition of caspase 3 activation in cells treated with antimycin A and the 
slow-releasing H2S donor, GYY4137 (100 µM). HeLa cells were incubated with antimycin A 
(300 µM) overnight to induce Cyt C release from mitochondria. GYY4137 when used, was 
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added 2 h prior to antimycin A. Caspase 3 activity was monitored in cell lysates as described 
in B. E) Persulfidation of procaspase 9 in HeLa cells treated with 2.5 µM ST (1) that were 
either pretreated for 2 h (2) or treated for the last 2 h (3) with GYY4137 (100 µM). (Left) Total 
procaspase 9 levels. (Right) Persulfidation (PSSH) levels of procaspase 9. PSSH levels 
were quantified by measuring the difference in fluorescence between DTT treated and 
untreated samples and normalizing this to the total procaspase 9 levels. The strategy used 
for sample processing to detect total versus persulfidated procaspase 9 is explained in 
Supporting Information and Supporting Fig. 5. 
 
Several caspases, including caspase 9 are inhibited by S-nitrosation of the active site 
cysteine.43,44 Several mechanisms have been proposed to explain the antiapoptotic effects 
of sulfide.45,46 We provide evidence that reactive sulfur species generated by Cyt C mediated 
H2S oxidation can tag proteins with the cysteine persulfide modification. We posit that this 
reactivity might be enhanced under hypoxic conditions when H2S oxidation is inhibited, or 
under apoptotic conditions when Cyt C is released into the cytoplasm and is disconnected 
from its mitochondrial electron donors e.g. complex III. If H2S synthesis is upregulated under 
these conditions, persulfidation of protein targets in the proximity of Cyt C like procaspase 9, 
will result. Inhibition of caspase 9 activity by persulfidation opens up the possibility of 
designing peptidomimetic persulfide donors to inhibit its activity, similar to the reported S-
nitrosothiol containing peptide.47  
In summary, we propose that the reaction between Cyt C and H2S results in the initial 
formation of a HS•/S•– radical. In a cellular milieu, HS•/S•– could suffer one of at least two 
fates: (i) be trapped by proteins, forming protein persulfides and superoxide, or (ii) be 
trapped by oxygen forming HSO2• (Fig. 7). Dismutation of superoxide generated in (i) would 
give H2O2, which together with H2S, could lead to more persulfidation.48 Formation of HSO2• 
in (ii) could further facilitate Cyt C reduction, resulting in sulfite and thiosulfate production. 
Cyt C reduction by H2S can fuel the ETC, bypassing complex III. Oxidation of Cyt C by 
complex IV would allow it to cycle between sulfide and the ETC, potentially leading to 
accumulation of reactive sulfur species. Cyt C-assisted protein persulfidation might 
represent a previously unrecognized source of reactive sulfur species that mediates the 
protective effects attributed to protein persulfidation.  
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Figure 7. Protein persulfidation catalyzed by cyt C/H2S couple. 
 
Methods 
Reagents. Antimycin A, equine heart ferric Cyt C, HSA, iodoacetamide and Na2S 
nonahydrate (99.99%) were purchased from Sigma Aldrich. Sodium disulfide (Na2S2) was 
from Dojindo Molecular Technologies, monobromobimane FluoroPure grade was from 
Molecular Probes (Grand Island, NY). GYY4137, AP39 and MeRho-Az were synthesized in-
house as described, respectively35,36,49. 2-(methylsulfonyl)-1,3-benzothiazole was from Santa 
Cruz Biotechnology and CN-Cy3 synthesized as reported previously.33 Murine procaspase 9 
was from Enzo Life Science. The siRNA for Cyt C was purchased from Santa Cruz 
Biotechnology. For the anaerobic experiments, buffers were purged with argon. To maintain 
high purity, Na2S solutions were made in an argon box by dissolving solid Na2Sx9H2O into 
argon purged water, as recommended2,19. 
 
Cell culture. Human colon cancer (HT29), hepatocellular carcinoma (HepG2), cervical 
cancer (HeLa) and immortalized human T-lymphocyte (Jurkat) cell lines were purchased 
from ATCC. Cells were cultured in 10 cm plates in EMEM (HepG2) or RPMI 1640 (HT29) 
medium supplemented with 10% FBS (Gibco) and 1% penicillin (10,000 U ml–
1)/streptomycin (10000 µg ml1) mixture (Gibco). Jurkat and HeLa cells were cultured in 75 
cm flasks in complete RPMI medium or DMEM (Sigma Aldrich) respectively, supplemented 
cyt C3+
cyt C2+
HS
HS
PSH PSSH
O2 O2 H2O2
PSOH PSSH
H2S
HSO2 SO32   /S2O32
O2, 4H+
2H2O
Com
plex IV
PSH
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with 10% FBS and 1% penicillin (10,000 U ml–1)/streptomycin (10000 µg ml–1) mixture 
(Sigma Aldrich). 
Detailed description of the methods is given in supporting information. 
 
Acknowledgment. This work was supported by the French State in the frame of the 
”Investments for the future” Programme IdEx Bordeaux, reference ANR-10-IDEX-03-02 and 
by ATIP-AVENIR grant (to M. R. F.),National Institutes of Health (GM112455 to R. B; 
R01GM113030 to MP), the Medical Research Council, UK (MR/M022706/1 to MW), the 
National Science Foundation (DGE-1309047 to AS), and the Brian Ridge Scholarship (RT). 
The authors are grateful to Marie-France Giraud (IBGC) for the help with mitochondria 
purification. 
 
Conflict of Interest: MW has patents on the therapeutic and agricultural use of 
mitochondria-targeted, and other, hydrogen sulfide delivery molecules.  
 
Author contributions: VV – design of experiments, spectral analysis of Cyt C interaction 
with sulfide and hydrodisulfide, pH dependence of Cyt C reaction with sulfide, oxygen 
consumption assays, data analysis, writing manuscript; JLJM – performed experiments with 
Cyt C siRNA, with fluorescence microscopy, caspase activity, flow cytometry, mitochondrial 
persulfidation, data analysis, writing manuscript; TB–oxygen consumption assays with Cyt 
C, data analysis, writing manuscript; BA – fluorescence microscopy, H2S measurements, 
HSA persulfidation; PKY - performed and analyzed the stopped-flow kinetic studies; AS, MP, 
RT, MW – contributed new analytical tools and MP and MW co-wrote the manuscript. RB – 
helped design kinetic, spectroscopic and OCR experiments, analyzed the data and co-wrote 
the manuscript; MRF – design of experiments, mass spectrometry, persulfidation of ATR 
and ETHE1, data analysis, writing manuscript. 
 
Supporting Information Available: This material is available free of charge via the Internet. 
	19	
 
References 
(1)  Keilin, D. Cytochrome and Respiratory Enzymes. Proc. R. Soc. London. Ser. B, 
Contain. Pap. a Biol. Character 1929, 104 (730), 206–252. 
(2)  Filipovic, M. R.; Zivanovic, J.; Alvarez, B.; Banerjee, R. Chemical Biology of H2S 
Signaling through Persulfidation. Chemical Reviews. 2018, pp 1253–1337. 
(3)  Kimura, H. Hydrogen Sulfide: From Brain to Gut. Antioxid. Redox Signal. 2010, 12 (9), 
1111–1123. 
(4)  Kabil, O.; Banerjee, R. Redox Biochemistry of Hydrogen Sulfide. J. Biol. Chem. 2010, 
285 (29), 21903–21907. 
(5)  Kabil, O.; Motl, N.; Banerjee, R. H2S and Its Role in Redox Signaling. Biochim. 
Biophys. Acta - Proteins Proteomics 2014, 1844 (8), 1355–1366. 
(6)  Singh, S.; Padovani, D.; Leslie, R. A.; Chiku, T.; Banerjee, R. Relative Contributions 
of Cystathionine β-Synthase and γ-Cystathionase to H2S Biogenesis via Alternative 
Trans-Sulfuration Reactions. J. Biol. Chem. 2009, 284 (33), 22457–22466. 
(7)  Chiku, T.; Padovani, D.; Zhu, W.; Singh, S.; Vitvitsky, V.; Banerjee, R. H2S 
Biogenesis by Human Cystathionine  Gamma-Lyase Leads to the Novel Sulfur 
Metabolites Lanthionine and Homolanthionine and Is Responsive to the Grade of 
Hyperhomocysteinemia. J. Biol. Chem. 2009, 284 (17), 11601–11612. 
(8)  Shibuya, N.; Tanaka, M.; Yoshida, M.; Ogasawara, Y.; Togawa, T.; Ishii, K.; Kimura, 
H. 3-Mercaptopyruvate Sulfurtransferase Produces Hydrogen Sulfide and Bound 
Sulfane Sulfur in the Brain. Antioxid. Redox Signal. 2009, 11 (4), 703–714. 
(9)  Yadav, P. K.; Yamada, K.; Chiku, T.; Koutmos, M.; Banerjee, R. Structure and Kinetic 
Analysis of H2S Production by Human Mercaptopyruvate Sulfurtransferase. J. Biol. 
Chem. 2013, 288 (27), 20002–20013. 
(10)  Kabil, O.; Banerjee, R. Characterization of Patient Mutations in Human Persulfide 
Dioxygenase (ETHE1) Involved in H2S Catabolism. J. Biol. Chem. 2012, 287 (53), 
44561–44567. 
	20	
(11)  Kabil, O.; Vitvitsky, V.; Banerjee, R. Sulfur as a Signaling Nutrient Through Hydrogen 
Sulfide. Annu. Rev. Nutr. 2014, 34 (1), 171–205. 
(12)  Hildebrandt, T. M.; Grieshaber, M. K. Three Enzymatic Activities Catalyze the 
Oxidation of Sulfide to Thiosulfate in Mammalian and Invertebrate Mitochondria. 
FEBS J. 2008, 275 (13), 3352–3361. 
(13)  Vitvitsky, V.; Yadav, P. K.; Kurthen, A.; Banerjee, R. Sulfide Oxidation by a 
Noncanonical Pathway in Red Blood Cells Generates Thiosulfate and Polysulfides. J. 
Biol. Chem. 2015, 290 (13), 8310–8320. 
(14)  Vitvitsky, V.; Yadav, P. K.; An, S.; Seravalli, J.; Cho, U.-S.; Banerjee, R. Structural 
and Mechanistic Insights into Hemoglobin-Catalyzed Hydrogen Sulfide Oxidation and 
the Fate of Polysulfide Products. J. Biol. Chem. 2017, 292 (13), 5584–5592. 
(15)  Bostelaar, T.; Vitvitsky, V.; Kumutima, J.; Lewis, B. E.; Yadav, P. K.; Brunold, T. C.; 
Filipovic, M.; Lehnert, N.; Stemmler, T. L.; Banerjee, R. Hydrogen Sulfide Oxidation by 
Myoglobin. J. Am. Chem. Soc. 2016, 138 (27). 
(16)  Ruetz, M.; Kumutima, J.; Lewis, B. E.; Filipovic, M. R.; Lehnert, N.; Stemmler, T. L.; 
Banerjee, R. A Distal Ligand Mutes the Interaction of Hydrogen Sulfide with Human 
Neuroglobin. J. Biol. Chem. 2017, 292 (16). 
(17)  Riedl, S. J.; Salvesen, G. S. The Apoptosome: Signalling Platform of Cell Death. 
Nature Reviews Molecular Cell Biology. 2007, pp 405–413. 
(18)  Nicholls, P.; Kim, J. K. Oxidation of Sulphide by Cytochrome aa3. Biochim. Biophys. 
Acta 1981, 637 (2), 312–320. 
(19)  Wedmann, R.; Bertlein, S.; Macinkovic, I.; Böltz, S.; Miljkovic, J. L.; Muñoz, L. E.; 
Herrmann, M.; Filipovic, M. R. Working with “H2S”: Facts and Apparent Artifacts. 
Nitric Oxide 2014, 41, 85–96. 
(20)  Koppenol, W. H.; Bounds, P. L. Signaling by Sulfur-Containing Molecules. 
Quantitative Aspects. Arch. Biochem. Biophys. 2017, 617, 3–8. 
(21)  Battistuzzi, G.; Borsari, M.; Cowan, J. A.; Ranieri, A.; Sola, M. Control of Cytochrome 
c Redox Potential: Axial Ligation and Protein Environment Effects. J. Am. Chem. Soc. 
	21	
2002, 124 (19), 5315–5324. 
(22)  Collman, J. P.; Ghosh, S.; Dey, A.; Decreau, R. A. Using a Functional Enzyme Model 
to Understand the Chemistry behind Hydrogen Sulfide Induced Hibernation. Proc. 
Natl. Acad. Sci. 2009, 106 (52), 22090–22095. 
(23)  Doeller, J. E.; Grieshaber, M. K.; Kraus, D. W. Chemolithoheterotrophy in a Metazoan 
Tissue: Thiosulfate Production Matches ATP Demand in Ciliated Mussel Gills. J. Exp. 
Biol. 2001, 204 (0022–0949 (Print)), 3755–3764. 
(24)  Hu, L.; Lu, M.; Wu, Z.; Wong, P. T.-H.; Bian, J. Hydrogen Sulfide Inhibits Rotenone-
Induced Apoptosis via Preservation of Mitochondrial Function. Mol. Pharmacol. 2009, 
75 (1), 27–34. 
(25)  Battistuzzi, G.; Borsari, M.; Dallari, D.; Lancellotti, I.; Sola, M. Anion Binding to 
Mitochondrial Cytochromes c Studied through Electrochemistry Effects of the 
Neutralization of Surface Charges on the Redox Potential. Eur. J. Biochem. 1996, 
241, 208–214. 
(26)  Radi, R.; Thomson, L.; Rubbo, H.; Prodanov, E. Cytochrome c-Catalyzed Oxidation of 
Organic Molecules by Hydrogen Peroxide. Arch. Biochem. Biophys. 1991, 288 (1), 
112–117. 
(27)  Alvarez-Paggi, D.; Hannibal, L.; Castro, M. A.; Oviedo-Rouco, S.; Demicheli, V.; 
Tórtora, V.; Tomasina, F.; Radi, R.; Murgida, D. H. Multifunctional Cytochrome c: 
Learning New Tricks from an Old Dog. Chem. Rev. 2017, 117 (21), 13382–13460. 
(28)  Mottley, C.; Mason, R. P.; Chignell, C. F.; Sivarajah, K.; Eling, T. E. The Formation of 
Sulfur Trioxide Radical Anion during the Prostaglandin Hydroperoxidase-Catalyzed 
Oxidation of Bisulfite (Hydrated Sulfur Dioxide). J. Biol. Chem. 1982, 257 (9), 5050–
5055. 
(29)  Neta, P.; Huie, R. E. Free-Radical Chemistry of Sulfite. Environ. Health Perspect. 
1985, VOL. 64, 209–217. 
(30)  Mottley, C.; Trice, T. B.; Mason, R. P. Direct Detection of the Sulfur Trioxide Radical 
Anion during the Horseradish Peroxidase-Hydrogen Peroxide Oxidation of Sulfite 
	22	
(Aqueous Sulfur Dioxide). Mol. Pharmacol. 1982, 22, 732–737. 
(31)  Yadav, P. K.; Martinov, M.; Vitvitsky, V.; Seravalli, J.; Wedmann, R.; Filipovic, M. R.; 
Banerjee, R. Biosynthesis and Reactivity of Cysteine Persulfides in Signaling. J. Am. 
Chem. Soc. 2016, 138 (1), 289–299. 
(32)  Zhang, D.; MacInkovic, I.; Devarie-Baez, N. O.; Pan, J.; Park, C.-M.; Carroll, K. S.; 
Filipovic, M. R.; Xian, M. Detection of Protein S-Sulfhydration by a Tag-Switch 
Technique. Angew. Chemie - Int. Ed. 2014, 53 (2). 
(33)  Wedmann, R.; Onderka, C.; Wei, S.; Szijártó, I. A.; Miljkovic, J. L.; Mitrovic, A.; Lange, 
M.; Savitsky, S.; Yadav, P. K.; Torregrossa, R.; et al. Improved Tag-Switch Method 
Reveals That Thioredoxin Acts as Depersulfidase and Controls the Intracellular 
Levels of Protein Persulfidation. Chem. Sci. 2016, 7 (5). 
(34)  Buettner, G. R. The Pecking Order of Free Radicals and Antioxidants: Lipid 
Peroxidation, a-Tocopherol, and Ascorbate. Archives of biochemistry and biophysics. 
1993, pp 535–543. 
(35)  Hammers, M. D.; Taormina, M. J.; Cerda, M. M.; Montoya, L. A.; Seidenkranz, D. T.; 
Parthasarathy, R.; Pluth, M. D. A Bright Fluorescent Probe for H2S Enables Analyte-
Responsive, 3D Imaging in Live Zebrafish Using Light Sheet Fluorescence 
Microscopy. J. Am. Chem. Soc. 2015, 137 (32), 10216–10223. 
(36)  Le Trionnaire, S.; Perry, A.; Szczesny, B.; Szabo, C.; Winyard, P. G.; Whatmore, J. L.; 
Wood, M. E.; Whiteman, M. The Synthesis and Functional Evaluation of a 
Mitochondria-Targeted Hydrogen Sulfide Donor, (10-Oxo-10-(4-(3-Thioxo-3H-1,2-
Dithiol-5-Yl)phenoxy)decyl)triphenylphosphonium Bromide (AP39). Med. Chem. 
Commun. 2014, 5 (6), 728–736. 
(37)  Arndt, S.; Baeza-Garza, C. D.; Logan, A.; Rosa, T.; Wedmann, R.; Prime, T. A.; 
Martin, J. L.; Saeb-Parsy, K.; Krieg, T.; Filipovic, M. R.; et al. Assessment of H2S in 
Vivo Using the Newly Developed Mitochondria-Targeted Mass Spectrometry Probe 
MitoA. J. Biol. Chem. 2017, 292 (19), 7761–7773. 
(38)  Garrido, C.; Galluzzi, L.; Brunet, M.; Puig, P. E.; Didelot, C.; Kroemer, G. Mechanisms 
	23	
of Cytochrome c Release from Mitochondria. Cell Death and Differentiation. 2006, pp 
1423–1433. 
(39)  Cai, J.; Yang, J.; Jones, D. P. Mitochondrial Control of Apoptosis: The Role of 
Cytochrome C. Biochim. Biophys. Acta 1998, 1366 (1–2), 139–149. 
(40)  Li, P.; Nijhawan, D.; Budihardjo, I.; Srinivasula, S. M.; Ahmad, M.; Alnemri, E. S.; 
Wang, X. Cytochrome c and dATP-Dependent Formation of Apaf-1/caspase-9 
Complex Initiates an Apoptotic Protease Cascade. Cell 1997, 91 (4), 479–489. 
(41)  Luetjens, C. M.; Kögel, D.; Reimertz, C.; Düßmann, H.; Renz, A.; Schulze-Osthoff, K.; 
Nieminen, A.-L.; Poppe, M.; Prehn, J. H. M. Multiple Kinetics of Mitochondrial 
Cytochrome c Release in Drug-Induced Apoptosis. Mol. Pharmacol. 2001, 60 (5). 
(42)  Zou, H.; Yang, R.; Hao, J.; Wang, J.; Sun, C.; Fesik, S. W.; Wu, J. C.; Tomaselli, K. 
J.; Armstrong, R. C. Regulation of the Apaf-1/Caspase 9 Apoptosome by Caspase-3 
and XIAP. J. Biol. Chem. 2002, in press. 
(43)  Kim, J.-E.; Tannenbaum, S. R. S-Nitrosation Regulates the Activation of Endogenous 
Procaspase-9 in HT-29 Human Colon Carcinoma Cells. J. Biol. Chem. 2004, 279 
(11), 9758–9764. 
(44)  Mannick, J. B.; Schonhoff, C.; Papeta, N.; Ghafourifar, P.; Szibor, M.; Fang, K.; 
Gaston, B. S-Nitrosylation of Mitochondrial Caspases. J. Cell Biol. 2001, 154 (6), 
1111–1116. 
(45)  Sivarajah, A.; Collino, M.; Yasin, M.; Benetti, E.; Gallicchio, M.; Mazzon, E.; 
Cuzzocrea, S.; Fantozzi, R.; Thiemermann, C. Anti-Apoptotic and Anti-Inflammatory 
Effects of Hydrogen Sulfide in a Rat Model of Regional Myocardial I/R. Shock 2009, 
31 (3), 267–274. 
(46)  Sen, N.; Paul, B. D.; Gadalla, M. M.; Mustafa, A. K.; Sen, T.; Xu, R.; Kim, S.; Snyder, 
S. H. Hydrogen Sulfide-Linked Sulfhydration of NF-κB Mediates Its Antiapoptotic 
Actions. Mol. Cell 2012, 45 (1), 13–24. 
(47)  Mitchell, D. A.; Morton, S. U.; Marletta, M. A. Design and Characterization of an Active 
Site Selective Caspase-3 Transnitrosating Agent. ACS Chem. Biol. 2006, 1 (10), 659–
	24	
665. 
(48)  Cuevasanta, E.; Lange, M.; Bonanata, J.; Coitiño, E. L.; Ferrer-Sueta, G.; Filipovic, M. 
R.; Alvarez, B. Reaction of Hydrogen Sulfide with Disulfide and Sulfenic Acid to Form 
the Strongly Nucleophilic Persulfide. J. Biol. Chem. 2015, 290 (45). 
(49)  Alexander, B. E.; Coles, S. J.; Fox, B. C.; Khan, T. F.; Maliszewski, J.; Perry, A.; 
Pitak, M. B.; Whiteman, M.; Wood, M. E.; Nakashima, I.; et al. Investigating the 
Generation of Hydrogen Sulfide from the Phosphonamidodithioate Slow-Release 
Donor GYY4137. Med. Chem. Commun. 2015, 6 (9), 1649–1655. 
 
 	
